It lobbied on multiple bills involving the Medicare prescription drug program that would either limit discounts given to the government or lowers the prices it pays.

Johnson & Johnson lobbied for expansion of the Children’s Health Insurance Program, on a bill to require research comparing the effectiveness of various medical treatments, and on legislation to establish a way for generic versions of biologic drugs to be approved.